Efficacy and safety study of intratympanic dexamethasone treatment concurrent with standard oral prednisolone treatment for facial palsy
- Conditions
- Facial nerve palsy
- Registration Number
- JPRN-UMIN000031107
- Lead Sponsor
- agoya City University, Graduate school of Medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 53
Not provided
Presence of non-viral inflammation in the idle ear. The presence of the carriage state of viral or bacterial disease. Middle ear or inner ear anomaly which makes it impossible to inject to the middle ear. HbA1C > 6.5% BUN >25 mg/dl or Serum creatinine level>2.0 mg/dl ALT > 100 U/l or AST > 100/l Severe protracted wound healing. Signs of central facial palsy Pregnancy, or possible pregnancy Participate in other clinical traials within 3 months Recurrent facial palsy Treatment other than 60 mg of prednisolone and 1000 mg (Bell's palsy) or 3000 mg (Hunt syndrome)of oral valaciclovir within two days straight History of facial nerve decompression surgery The patients who are considered not to be appropriate for the clinical trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method